Updated On: 20 May, 2021 07:49 AM IST | Washington | Agencies
A study shows that the newly identified SARS-CoV-2 variants found in India are neutralised well by antibodies in individuals vaccinated with both vaccines

A waitress holds customers’ orders at a restaurant terrace in the Strasbourg district of La Petite-France. Pic/AFP
Covid-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study.
The study shows that the newly identified SARS-CoV-2 variants identified in India are neutralised well by antibodies in individuals vaccinated with both vaccines.